https://www.selleckchem.com/pr....oducts/pi3k-hdac-inh
Next-generation sequencing (NGS) might represent a valuable diagnostic tool to identify somatic alterations and enable personalised medicine in uro-oncology. We aim to determine feasibility and impact of routine NGS in clinical practice. Tumours from patients with genitourinary cancers were subjected to NGS. Results were discussed in a dedicated molecular tumour board. Statistical analyses included chi-square test and Mann-Whitney U test. Between 2017 and 2020, 65 patients with advanced genitourinary cancers were consecuti
Like
Comment
Share
